Literature DB >> 25062285

Surgical outcomes and natural history of intramedullary spinal cord cavernous malformations: a single-center series and meta-analysis of individual patient data: Clinic article.

Jetan H Badhiwala1, Forough Farrokhyar, Waleed Alhazzani, Blake Yarascavitch, Mohammed Aref, Almunder Algird, Naresh Murty, Edward Kachur, Aleksa Cenic, Kesava Reddy, Saleh A Almenawer.   

Abstract

OBJECT: Information pertaining to the natural history of intramedullary spinal cord cavernous malformations (ISCCMs) and patient outcomes after surgery is scarce. To evaluate factors associated with favorable outcomes for patients with surgically and conservatively managed ISCCMs, the authors performed a systematic review and metaanalysis of the literature. In addition, they included their single-center series of ISCCMs.
METHODS: The authors searched MEDLINE, EMBASE, CINAHL, Google Scholar, and The Cochrane Library for studies published through June 2013 that reported cases of ISCCMs. Data from all eligible studies were used to examine the epidemiology, clinical features, and neurological outcomes of patients with surgically managed and conservatively treated ISCCMs. To evaluate several variables as predictors of favorable neurological outcomes, the authors conducted a meta-analysis of individual patient data and performed univariate and multivariate logistic regression analyses. Variables included patient age, patient sex, lesion spinal level, lesion size, cerebral cavernomas, family history of cavernous malformations, clinical course, presenting symptoms, treatment strategy (operative or conservative), symptom duration, surgical approach, spinal location, and extent of resection. In addition, they performed a meta-analysis to determine a pooled estimate of the annual hemorrhage rate of ISCCMs.
RESULTS: Eligibility criteria were met by 40 studies, totaling 632 patients, including the authors' institutional series of 24 patients. Mean patient age was 39.1 years (range 2-80 years), and the male-to-female ratio was 1.1:1. Spinal levels of cavernomas were cervical (38%), cervicothoracic (2.4%), thoracic (55.2%), thoracolumbar (0.6%), lumbar (2.1%), and conus medullaris (1.7%). Average cavernoma size was 9.2 mm. Associated cerebral cavernomas occurred in 16.5% of patients, and a family history of cavernous malformation was found for 11.9% of evaluated patients. Clinical course was acute with stepwise progression for 45.4% of patients and slowly progressive for 54.6%. Symptoms were motor (60.5%), sensory (57.8%), pain (33.8%), bladder and/or bowel (23.6%), respiratory distress (0.5%), or absent (asymptomatic; 0.9%). The calculated pooled annual rate of hemorrhage was 2.1% (95% CI 1.3%-3.3%). Most (89.9%) patients underwent resection, and 10.1% underwent conservative management (observation). Outcomes were better for those who underwent resection than for those who underwent conservative management (OR 2.79, 95% CI 1.46-5.33, p = 0.002). A positive correlation with improved neurological outcomes was found for resection within 3 months of symptom onset (OR 2.11, 95% CI 1.31-3.41, p = 0.002), hemilaminectomy approach (OR 3.20, 95% CI 1.16-8.86, p = 0.03), and gross-total resection (OR 3.61, 95% CI 1.24-10.52, p = 0.02). Better outcomes were predicted by an acute clinical course (OR 1.72, 95% CI 1.10-2.68, p = 0.02) and motor symptoms (OR 1.76, 95% CI 1.08-2.86, p = 0.02); poor neurological recovery was predicted by sensory symptoms (OR 0.58, 95% CI 0.35-0.98, p = 0.04). Rates of neurological improvement after resection were no higher for patients with superficial ISCCMs than for those with deep-seated ISCCMs (OR 1.36, 95% CI 0.71-2.60, p = 0.36).
CONCLUSIONS: Intramedullary spinal cord cavernous malformations tend to be clinically progressive. The authors' findings support an operative management plan for patients with a symptomatic ISCCM. Surgical goals include gross-total resection through a more minimally invasive hemilaminectomy approach within 3 months of presentation.

Entities:  

Keywords:  ISCCM = intramedullary spinal cord cavernous malformation; cavernous hemangioma; cavernous malformation; intramedullary spinal cord lesion; meta-analysis; spine; systematic review; vascular disorders; vascular malformations

Mesh:

Year:  2014        PMID: 25062285     DOI: 10.3171/2014.6.SPINE13949

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  20 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

Review 2.  Enhanced recovery after surgery in intramedullary and extramedullary spinal cord lesions: perioperative considerations and recommendations.

Authors:  Sauson Soldozy; Parantap Patel; Mazin Elsarrag; Pedro Norat; Daniel M Raper; Jennifer D Sokolowski; Kaan Yağmurlu; Min S Park; Petr Tvrdik; M Yashar S Kalani
Journal:  Spinal Cord       Date:  2019-07-29       Impact factor: 2.772

3.  A retrospective and consecutive analysis of the epidemiology and management of spinal cavernomas over the last 20 years in a single center.

Authors:  Ardeshir Ardeshiri; Neriman Özkan; Bixia Chen; Klaus-Peter Stein; Dorothea Miller; Bernd-Otto Hütter; Ibrahim Erol Sandalcioglu; Ulrich Sure
Journal:  Neurosurg Rev       Date:  2015-12-02       Impact factor: 3.042

Review 4.  Prognostic factors for surgically managed intramedullary spinal cord tumours: a single-centre case series.

Authors:  Asfand Baig Mirza; Axumawi Gebreyohanes; James Knight; James Bartram; Amisha Vastani; Dimitrios Kalaitzoglou; Jose Pedro Lavrador; Ahilan Kailaya-Vasan; Eleni Maratos; David Bell; Nick Thomas; Richard Gullan; Irfan Malik; Gordan Grahovac
Journal:  Acta Neurochir (Wien)       Date:  2022-07-13       Impact factor: 2.816

Review 5.  A systematic review on the outcome of intramedullary spinal cord cavernous malformations.

Authors:  Evridiki Asimakidou; Lieropi Tzanetaki Meszaros; Dimitrios M Anestis; Parmenion P Tsitsopoulos
Journal:  Eur Spine J       Date:  2022-08-06       Impact factor: 2.721

6.  High Prevalence of Spinal Cord Cavernous Malformations in the Familial Cerebral Cavernous Malformations Type 1 Cohort.

Authors:  M C Mabray; J Starcevich; J Hallstrom; M Robinson; M Bartlett; J Nelson; A Zafar; H Kim; L Morrison; B L Hart
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-28       Impact factor: 3.825

Review 7.  Systemic and CNS manifestations of inherited cerebrovascular malformations.

Authors:  Blaine L Hart; Marc C Mabray; Leslie Morrison; Kevin J Whitehead; Helen Kim
Journal:  Clin Imaging       Date:  2021-01-20       Impact factor: 2.420

8.  KRIT1 mutations in three Japanese pedigrees with hereditary cavernous malformation.

Authors:  Kengo Hirota; Hiroyuki Akagawa; Asami Kikuchi; Hideki Oka; Akihiko Hino; Tetsuryu Mitsuyama; Toshiyuki Sasaki; Hideaki Onda; Takakazu Kawamata; Hidetoshi Kasuya
Journal:  Hum Genome Var       Date:  2016-10-06

9.  Spinal Cavernomas: Outcome of Surgically Treated 10 Patients.

Authors:  Ibrahim Sun; M Necmettin Pamir
Journal:  Front Neurol       Date:  2017-12-20       Impact factor: 4.003

10.  A Case of Atopic Myelitis with Cervical Cavernous Angioma.

Authors:  Miyuki Fukuda; Hiroaki Manabe; Nobuhiro Sasaki; Masayuki Kuroda; Minoru Hoshimaru; Shigeo Ueda
Journal:  Case Rep Med       Date:  2017-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.